Category: Press Release

Explore all our news . .

Recent Posts

Nyxoah Appoints Scott Holstine as Chief Commercial Officer

Nyxoah Appoints Scott Holstine as Chief Commercial Officer Mont-Saint-Guibert, Belgium – July 15, 2024, 8:00am CET / 2:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced

‫2024 چین گوانسیان سٹیل پلیٹ انڈسٹری اوپننگ اپ اور بین الاقوامی پریسیشن پروکیورمنٹ کانفرنس گوانگچوئر کاؤنٹی،شانڈونگ صوبے میں منعقد ہوئی

گوانسیان، چین، 4 جولائی 2024ئ/سنہوا-ایشیانیٹ/– “عالمی تجارت کے لئے شانڈونگ اچھی مصنوعات” کے موضوع کے تحت 2024 چین گوانسیان سٹیل پلیٹ انڈسٹری اوپننگ اپ اور بین الاقوامی پریسیشن پروکیورمنٹ کانفرنس 26 سے 28 جون تک گوانسیان کاؤنٹی میں منعقد ہوئی۔ اسٹیل پلیٹ کی صنعت گوانسیان کاؤنٹی کی ایک منفرد اور

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the first gene therapy administered as a treatment

The 2024 China Guanxian Steel Plate Industry Opening-up and International Precision Procurement Conference held in Guanxian County, Shandong Province

GUANXIAN, China, July 3, 2024 /Xinhua-AsiaNet/– The 2024 China Guanxian Steel Plate Industry Opening-up and International Precision Procurement Conference under the theme of “Shandong Good Products for Global Trade” was held in Guanxian County from June 26 to 28. The steel plate industry is a distinctive pillar industry of Guanxian

Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank

REGULATED INFORMATION INSIDE INFORMATION Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank Mont-Saint-Guibert, Belgium – July 3, 2024, 12:30pm CET / 6:30am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of